Navigation Links
DrugRisk News: Federal Panel Issues Latest Mirena Lawsuit Updates
Date:5/15/2013

New York, NY (PRWEB) May 15, 2013

The birth control safety advocates at DrugRisk.com are announcing new information on the site for women using Bayer’s contraceptive device Mirena. A federal judicial panel recently updated the amount of injury claims that have been filed by patients in a special court*.

DrugRisk was created to improve the safety of patients using popular medication devices by providing the latest product news, safety alerts, research and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice.

The resource center has added warnings from health experts about the risk of perforation from IUDs such as Mirena. A study published by the Journal of the Society of Laparoendoscopic Surgeons warns patients about migration and perforation of Mirena IUDs after implantation**.

With a growing number of patients filing a Mirena lawsuit, federal cases have been consolidated to a special multi-district litigation court in the Southern District of New York (In Re: Mirena IUD Products Liability Litigation, MDL No. 2434).

Now, DrugRisk has learned the latest update from the Judicial Panel on Multidistrict Litigation shows 46 claims have already been filed in the court*.

Anyone who suffered perforation or required surgery while using a Mirena IUD is urged to speak with a lawyer about their legal rights. Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers who are already handling Mirena lawsuits.

For more information on the research, side effects and litigation news related to Essure, Mirena or other birth control devices, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Judicial Panel on MultiDistrict Litigation, 5/15/13; jpml.uscourts.gov/sites/jpml/files/Pending%20MDL%20Dockets_By%20District_May-14-2013.pdf
**JSLS, 3/15/11; ncbi.nlm.nih.gov/pmc/articles/PMC3134688/

Read the full story at http://www.prweb.com/releases/2013-mirena-iud/birth-control-lawsuit/prweb10735443.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
2. DrugRisks Update: Yaz Class Action Begins in Canada as Settlements Continue in U.S.
3. DrugRisk Update: Byetta Maker Agrees With Transferring Lawsuits to Federal Court
4. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
5. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
6. DrugRisk Update: New Study Warns of Cancer in Byetta Side Effects
7. DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia
8. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
9. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
10. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
11. DrugRisk Announces Launch of Byetta Cancer Resource Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For the first ... solution to the exhibit floor for the 2017 HIMSS Conference & Exhibition ... Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental ... for each and every seminar, session and class she offers. At the ... tools which help energize creativity, focus mental functions, enhance athletic focus and skill ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, ... finalist in the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative ... work is recognized across multiple award categories, highlighting four of the organization’s current ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... by fall 2017 season , Trinity Health and the U.S. Soccer Foundation announced ... Success program in underserved communities. Soccer for Success, the Foundation’s soccer mentoring program, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting ... on all facets of clinical trial planning and management. Pharmica discussed the importance ... more. In addition, attendees stopping by Pharmica’s booth were able to demo its ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... DUBLIN , Feb. 17, 2017 ... ("Theravance Biopharma" or the "Company") today announced the ... novel, potent, and orally administered pan-Janus kinase (JAK) ... 12 th Congress of the European Crohn,s ... the Company reported further data from its completed ...
(Date:2/17/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and forecasts ... analysis is provided for these markets. Market data and analytics are derived ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017   ... other side effects allegedly associated with use of the ... Philadelphia Court of Common Pleas, ... a mass tort program. According to a notice posted ... scheduled to convene a meeting on March 9, 2017 ...
Breaking Medicine Technology: